Lundbeck Canada Inc. v. Sandoz Canada Inc.

Call to arrange a consultation

2024

T-971-22

Pending

6(1) PMNOC

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,655,212 and 2,705,163 (vortioxetine).

Counsel to:

Sandoz Canada Inc.

The decision is reported

Partner

Associate

Associate